Sign inGet started

Jones Elaine V

Insider CIK 1296907 · CTMX Director · MIRN Director · GRTS Director · NXTC Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NXTC NextCure, Inc. A Award deriv2026-06-182026-06-222,340— $02,340SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2026-06-172026-06-2259,000— $059,000SEC↗
NXTC NextCure, Inc. A Award deriv2025-06-202025-06-2418,700— $018,700SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2025-06-112025-06-1338,000— $038,000SEC↗
GRTS Gritstone bio, Inc. J Other deriv2025-04-042025-04-0819,000— $00SEC↗
GRTS Gritstone bio, Inc. J Other deriv2025-04-042025-04-0851,800— $00SEC↗
GRTS Gritstone bio, Inc. J Other deriv2025-04-042025-04-0815,942— $00SEC↗
GRTS Gritstone bio, Inc. J Other deriv2025-04-042025-04-0812,500— $00SEC↗
GRTS Gritstone bio, Inc. J Other deriv2025-04-042025-04-0851,800— $00SEC↗
GRTS Gritstone bio, Inc. J Other deriv2025-04-042025-04-0819,000— $00SEC↗
NXTC NextCure, Inc. A Award deriv2024-06-202024-06-2118,700— $018,700SEC↗
GRTS Gritstone bio, Inc. A Award deriv2024-06-172024-06-2051,800— $051,800SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2024-05-152024-05-1738,000— $038,000SEC↗
NXTC NextCure, Inc. A Award deriv2023-06-222023-06-2314,250— $014,250SEC↗
GRTS Gritstone bio, Inc. A Award deriv2023-06-162023-06-2151,800— $051,800SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2023-06-142023-06-1625,000— $025,000SEC↗
CTMX CytomX Therapeutics, Inc. P Buy2023-03-292023-03-315,000$1.55 $7.8K5,142SEC↗
NXTC NextCure, Inc. A Award deriv2022-06-232022-06-2414,250— $014,250SEC↗
GRTS Gritstone bio, Inc. A Award deriv2022-06-172022-06-2219,000— $019,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2022-06-152022-06-1725,000— $025,000SEC↗
NXTC NextCure, Inc. A Award deriv2021-06-242021-06-2814,250— $014,250SEC↗
GRTS Gritstone bio, Inc. A Award deriv2021-06-182021-11-1919,000— $019,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2021-06-162021-06-1720,000— $020,000SEC↗
GRTS Gritstone Oncology, Inc. A Award deriv2020-06-182020-06-2212,500— $012,500SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2020-06-172020-06-1720,000— $020,000SEC↗
NXTC NextCure, Inc. A Award deriv2020-06-112020-06-1514,250— $014,250SEC↗
GRTS Gritstone Oncology, Inc. A Award deriv2019-09-122019-09-1315,942— $015,942SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2019-06-192019-06-2114,000— $014,000SEC↗
NXTC NextCure, Inc. A Award deriv2019-06-132019-06-1722,000— $022,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2019-05-012019-05-0228,000— $028,000SEC↗
MIRN Mirna Therapeutics, Inc. A Award deriv2015-09-302015-09-307,200— $07,200SEC↗